R. Gaynor
Cancer Research · 2000–2020
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 47 citations into it; #549 of 1,780 by trust here, #1,041 by citations
- Oncology — 47 citations into it; #566 of 1,698 by trust here, #993 by citations
- Molecular Biology — 40 citations into it; #7,343 of 17,773 by trust here, #8,280 by citations
Whom R. Gaynor trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Gaynor overall
Papers from R. Gaynor's perspective
Ordered by how strongly the researchers R. Gaynor trusts endorse each paper. Same corpus, a different order for every researcher.
- Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase (Nature)
- The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
- Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB (Molecular and Cellular Biology)
- Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38* (Journal of Biological Chemistry)
- Signal transduction by tumor necrosis factor and its relatives. (Trends in Cell Biology)
- Signaling to NF-kappaB. (Genes & Development)
- NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
- Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation (Science)
- The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
- Dendritic cells: specialized and regulated antigen processing machines. (Cell)
Their papers
- Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. (2001) — 1,694 citations
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. (2020) — 621 citations
- IκB kinases: key regulators of the NF-κB pathway (2004) — 600 citations
- Nuclear Role of IκB Kinase-γ/NF-κB Essential Modulator (IKKγ/NEMO) in NF-κB-dependent Gene Expression* (2004) — 84 citations
- Regulation of β-Catenin Function by the IκB Kinases* (2001) — 121 citations
- Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1* (2000) — 177 citations